The Daily Herald Market Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
FDA Approves Gen-Probe’s PANTHER
By: DailyMarkets.com
Posted on May 11, 2012 at 12:52 PM EDT
Gen-Probe Inc. (NASDAQ:GPRO), a leading diagnostic devices company, recently announced the approval of the U.S. Food and Drug Administration (“FDA”) for its PANTHER system, an immunoassay instrument for molecular diagnosis. The system has been given the initial approval to be used with its market-leading chlamydia and gonorrhea test APTIMA COMBO 2. The PANTHER system can [...]

Gen-Probe Inc. (NASDAQ:GPRO), a leading diagnostic devices company, recently announced the approval of the U.S. Food and Drug Administration (“FDA”) for its PANTHER system, an immunoassay instrument for molecular diagnosis. The system has been given the initial approval to be used with its market-leading chlamydia and gonorrhea test APTIMA COMBO 2.
The PANTHER system can process a number of different molecular tests as well as generate results on all phases of nucleic acid testing (“NAT”) on … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards


Related Stocks:
Abbott Laboratories Becton, Dickinson & Co. Novartis AG ADS Roche Holding AG Basel American Depositary Shares
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here